To use this site, please disable the ad blocking feature and reload the page.
This website uses cookies to collect information about your visit for purposes such as showing you personalized ads and content, and analyzing our website traffic. By clicking “Accept all,” you will allow the use of these cookies.
Users accessing this site from EEA countries and UK are unable to view this site without your consent. We apologize for any inconvenience caused.
A Tokyo-based nonprofit organization called the Intractable Disease Patient Support Association is suspected of having facilitated a kidney transplant that used a trafficked organ from a living donor overseas. The Yomiuri Shimbun asked an experts in the relevant legal and medical systems for their opinion on this matter.
In this installment, we hear from Naoshi Shinozaki, former executive director of the Japan Organ Transplant Network.
※※※
The Yomiuri Shimbun Naoshi Shinozaki
“Transplant tourism,” in which people from advanced countries pay to receive organs from donors in developing countries, has been strongly denounced in the “Declaration of Istanbul” adopted by the Transplantation Society in 2008, among others.
It is natural for a patient with a serious illness to want to live, but in principle, transplant organs should come from the recipient’s home country.
Japanese people receiving transplants in developing countries have been criticized internationally. At a summit held in the Vatican in 2017 to combat organ trafficking, it was reported that two Japanese people had purchased kidneys and received transplants overseas.
Organizations that mediate transplants in developing countries and elsewhere cannot be left unchecked. Necessary measures must be taken to protect Japan’s credibility.
We must do something about the shortage of donors in Japan. In 2017, only 0.61 people per million in Japan donated organs, far below the 38.03 per million in the United States and 37.4 in Spain.
Public awareness of the issue is not low. In a survey conducted by the Cabinet Office last year, about 40% of respondents said they wanted to donate their organs or were leaning toward doing so. That compares favorably with figures in the United States and other countries.
The problem lies in Japan’s system, which does not take such desires sufficiently into consideration. Japan has a “system error.”
The only way to improve the situation is to implement thorough procedures in which health care workers explain about organ donation to the families of the deceased and obtain their approval.
In Spain, for example, trained doctors are appointed as coordinators in hospitals across the country, working in collaboration with other medical staff to explain to bereaved families about the harvesting and transplantation of organs.
In Japan, too, it is essential to train, educate and raise the awareness of doctors. Preferential treatment should also be considered for doctors who provide the necessary explanations to bereaved families, in the form of reimbursing their medical and technical service fees.
We need to do everything we can to increase the number of transplants.
— Naoshi Shinozaki specializes in biology, and has served as director of the Tokyo Dental College Cornea Center, among other posts. He was involved in the establishment of the Organ Transplant Law.
